Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
iShares Russell 2000 ETF
(NY:
IWM
)
251.82
+3.04 (+1.22%)
Official Closing Price
Updated: 4:10 PM EDT, Mar 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about iShares Russell 2000 ETF
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
Volatility Playbook: Key Levels And Market Catalysts To Watch Now
↗
February 24, 2025
Markets are at a crossroads as small caps hit key support and tech shows signs of exhaustion.
Via
Talk Markets
Topics
Stocks / Equities
UK's Cineworld Reportedly Eyes IPO Or Merger With AMC Or Cinemark: Retail Isn't Biting Yet
↗
February 24, 2025
Cineworld emerged from Chapter 11 bankruptcy in mid-2023, nearly 11 months after filing for it.
Via
Stocktwits
Topics
Bankruptcy
Initial Public Offering
Storm Clouds And Lightning Strikes Are Rolling In Over U.S. Stocks
↗
February 23, 2025
Nasdaq and S&P briefly hit new all-time highs before a dramatic reversal on Thursday and Friday which could be pointing to a failed breakout and double-top.
Via
Talk Markets
Topics
ETFs
Stocks
Stocks / Equities
The Inside Sectors Of The Economy Flash Warning
↗
February 23, 2025
Zooming out to the weekly chart of TLT, we see a double bottom in play from the lows in October 2023 and January 2025.
Via
Talk Markets
Topics
Commodities
ETFs
Economy
CoT: Peek Into The Future Thru Futures - How Hedge Funds Are Positioned, Feb. 23
↗
February 23, 2025
It is tough guessing how things will shake out in the next few weeks, let alone for the remainder of the year or the next four years. If there is any certainty, it is that it will be volatile.
Via
Talk Markets
Topics
Stocks / Equities
Bulls Fail At New Highs (For Now) – Nasdaq 100 Leading, Russell Still Lagging
↗
February 18, 2025
Via
Talk Markets
Topics
Stocks / Equities
S&P 500 Goes To Red... But..
↗
February 21, 2025
I’m sending this to you because the S&P 500 ETF (SPY) has moved under its 20-day moving average and outflows have accelerated on the Russell 2000 and the S&P 500.
Via
Talk Markets
Topics
ETFs
Stocks
Stocks / Equities
Stock Market Indices Suffer Significant Trend Change Following Friday's Session
↗
February 21, 2025
In this video, I review the market warnings I've shared over the past three weeks and how Friday's session confirmed negative divergences across key metrics signaling weakness.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Don't Call It A Stock Market Crash
↗
February 21, 2025
A look at what today's price action means from a technical analysis standpoint, and what you can do to be prepared for whatever the stock market throws your way.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
CarGurus Stock Slides After Mixed Q4 Results, Weak Guidance: Retail Mood Worsens
↗
February 21, 2025
Among key performance indicators, total paying dealers increased by 3%, and Quarterly Average Revenue per Subscribing Dealer (QARSD) gained 12% to $6,144.
Via
Stocktwits
Ardelyx Stock Rises After-Hours On Q4 Beat, Drug Sales Outlook: Retail Gets Big Dose Of Optimism
↗
February 20, 2025
Revenue for the quarter was $116.13 million, topping the consensus estimate of $111.16 million, driven by robust sales of its two approved drugs, Ibsrela and Xphozah.
Via
Stocktwits
Financial Markets Report For Thursday, Feb 20
↗
February 20, 2025
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Thursday, February 20.
Via
Talk Markets
Topics
Commodities
Cryptocurrencies
Currencies/Forex
Russell 2000 Earnings Dashboard 24Q4 - Thuersday, Feb. 20
↗
February 20, 2025
The 24Q4 Y/Y blended earnings growth estimate is 51.5%. If the energy sector is excluded, the growth rate for the index is 81.9%.
Via
Talk Markets
Topics
Stocks / Equities
S&P 500 Vs. Russell 2000: Are Small Caps Set For A Breakout?
↗
February 20, 2025
JPMorgan analyst notes S&P 500's struggle to break past 6,100 peak. Big caps hold ground, but small caps eyeing breakout. Investors should watch key levels and global cyclical trends for implications.
Via
Benzinga
Topics
Stocks
Palantir Rally Loses Steam, Walmart Outlook Disappoints: What's Driving Markets Thursday?
↗
February 20, 2025
Stocks tumbled Thursday, with all major indices in the red, one day after the S&P 500 notched another all-time high in Wednesday’s trading session.
Via
Benzinga
Fidelis Insurance Stock Headed Toward Worst Single-Day Decline After Disclosing Aviation Litigation, California Wildfires Impact
↗
February 20, 2025
During Q4, the company incurred a net adverse prior-year development of $287.2 million attributable to its Aviation and Aerospace line of business.
Via
Stocktwits
Candel Therapeutics Stock Rallies On Canaccord’s Vote Of Confidence In Lead Cancer Drug: Retail Traders Rejoice
↗
February 20, 2025
CAN-2409 could become a “best-in-class therapy” for borderline resectable pancreatic ductal adenocarcinoma, according to the analyst.
Via
Stocktwits
SpringWorks Therapeutics Gains Retail Interest Ahead Of Q4 Earnings – What Investors Expect
↗
February 20, 2025
Recent investor enthusiasm has been fueled by reports that German healthcare giant Merck KGaA is in advanced talks to acquire SpringWorks.
Via
Stocktwits
Financial Markets Report For Wednesday, Feb 19
↗
February 19, 2025
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Wednesday, February 19.
Via
Talk Markets
Topics
Commodities
Cryptocurrencies
Currencies/Forex
Does Plug Power Have Any Power To Rally?
↗
February 19, 2025
Plug Power is a key player in the push for sustainable energy, working to advance hydrogen as an alternative to fossil fuels in transportation, industrial power, and grid applications.
Via
Talk Markets
Topics
Stocks / Equities
S&P Pushes Through "Bull Trap"
↗
February 19, 2025
Today the S&P ticked all the boxes as it closed above the 'bull trap' in a fresh breakout that came with a higher volume accumulation.
Via
Talk Markets
Topics
Stocks
Stocks / Equities
George Soros Makes Fresh Bets On Alphabet, Small Caps: What About SPY Puts And Alibaba?
↗
February 19, 2025
Soros Fund Management made bullish bets on Alphabet and small-cap stocks while reducing exposure to SPY and Chinese tech in Q4.
Via
Benzinga
Trump Calls For More Tariffs, Federal Reserve Minutes On Deck: What's Driving Markets Wednesday?
↗
February 19, 2025
All three major U.S. indices are red in Wednesday's midday trading as investors weighed President Donald Trump's proposed tariffs on auto imports, pharmaceuticals and semiconductors.
Via
Benzinga
Topics
Economy
Government
World Trade
Cinemark Stock Plunges As Q4 EPS Miss Overshadows Record Revenue, Dividend Reinstatement: Retail Shrugs It Off
↗
February 19, 2025
CEO Sean Gamble attributed the company’s outsized box office proceeds to better-than-expected industry performance.
Via
Stocktwits
Solid Biosciences' Retail Following Swells Amid Stock's Best Run In A Year — What's Behind The Move?
↗
February 18, 2025
Early-stage data from the company's gene therapy candidate SGT-003 for Duchenne muscular dystrophy (DMD) showed encouraging results.
Via
Stocktwits
Financial Markets Report For Tuesday, Feb 18
↗
February 18, 2025
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Tuesday, February 18.
Via
Talk Markets
Topics
Commodities
Cryptocurrencies
Currencies/Forex
Axsome Therapeutics Stock Slips On Q4 Profit Miss, But Retail Takes It In Stride
↗
February 18, 2025
CEO Herriot Tabuteau struck an optimistic tone, citing strong commercial growth, a rapidly advancing pipeline, and the recent U.S. approval of Symbravo for migraine treatment.
Via
Stocktwits
US, Russia Begin Ukrainian Peace Talks, Intel Shares Surge: What's Driving Markets Tuesday?
↗
February 18, 2025
Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent geopolitical developments and anticipate the release of the latest FOMC minutes on Wednesday.
Via
Benzinga
Stocktwits Poll Shows 70% of Retail Either Holding Or Accumulating Gorilla Tech Stock Ahead Of Tuesday's Live Investor Webinar
↗
February 18, 2025
The company will explain in the webinar its positioning in the market for artificial intelligence-driven Internet of Things technology solutions, security convergence, and big data analytics.
Via
Stocktwits
Large-Caps, Including Tech, Itching To Break Out To Fresh High
↗
February 18, 2025
Large- and small-caps are diverging, with the former looking to break out to a fresh high and the latter stuck in a range well off its high.
Via
Talk Markets
Topics
Stocks / Equities
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.